WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'6201 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 4'1431 Child (under 5 years) mortality rate: 722

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 26'442  25'905  25'366  24'821  24'263  18'825  14'629  10'802 
Births 804  800  794  788  780  655  572  474 
Surviving infants 764  759  753  747  739  613  527  429 
Pop. less than 5 years 3'707  3'677  3'640  3'593  3'529  2'860  2'456  1'933 
Pop. less than 15 years 10'116  9'962  9'800  9'631  9'452  7'799  6'410  4'938 
Female 15-49 years 6'795  6'654  6'512  6'366  6'212  4'507  3'328  2'363 

Number of reported case

(Click for retrospective incidence data for Ghana)
Diphtheria 47  66  40 
Japanese encephalitis
Measles 124  319  1'613  120  641  23'068  32'246  82'684 
Mumps 3'780 
Pertussis 63  636  2'651  13'216 
Polio* 104  60  145 
Rubella 26  168  272  712 
Rubella (CRS)
Tetanus (neonatal) 80 
Tetanus (total)** 456  79  219  660  1'045 
Yellow fever 30  155 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ghana)
Vaccine year result method % card seen                                                
BCG 2011  99  EPI   98  99  98  98  98  99*  95  71 
DTP1 2011  100  EPI   98  99*  94  92  94  96  84 
DTP3 2011  97  EPI   98  98  90  92  91  94  84  50 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  97  EPI   98  98  90  92  91  94 
Hib3 2011  97  EPI   98  98  90  92  91  94 
JapEnc         
MCV1          92  89  89  91  93  84  52  16 
MCV2          67  54  52 
PCV1          99*  93  87 
PCV3          98  89  56 
Pol3 2011  97  EPI   98  98  91  91  91  94  83  50 
Rota1          99*  92  86 
Rota_last          98  87  77 
Rubella1          92  89 
TT2plus 2010  55  MICS   89  42  71  72  76  80  73  19 
PAB         
VAD1          98  36  35  51  13 
YFV 2011  93  EPI   98  92  87  89  91  93  74 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ghana)
BCG 99  98  98  98  99  99  71 
DTP1 99  94  92  94  96  96  80  27 
DTP3 98  90  92  91  94  88  58 
HepB3 98  90  92  91  94 
HepB_BD
Hib3 98  90  92  91  94 
MCV1 92  89  88  91  93  90  61  16 
MCV2 67  54  52 
PAB 88  88  88  88  86  69  60 
PCV3 98  89  43 
Pol3 98  91  91  91  94  88  57 
Rota_last 98  87  49 
YFV 92  87  88  91  93  74 

Number of districts in the country 216  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 19
From 50 to 79% 24
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From September 2015
MR 9 months; Yes
Measles 18 months; Yes
MenA 18 months; No From January 2016
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +1, +6 months; +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2010-2014  2010 - 2014  2010-2014  2010-2014  2010-2014  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 216  216  170  170  170  170  138 

System performance

Total Nº districts in country number 216  216  170  170  170  170  138 
Nº districts with DTP3 coverage >=80% number 164  162  136  144  134  153  117 
% of districts with DTP3 coverage >=80% From 0 to 100% 76  75  80  85  79  90  85 
Nº districts with measles (MCV1) coverage >=95% number 89  10  95  75  57  87  58 
% of districts with MCV1 coverage >=95% From 0 to 100% 41  56  44  34  51  42 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 19  16  13        70 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.